4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-002706
Chief Operating Officer sold 22,258 shares at $0.45 ($10,094)
- Chief Operating Officer acquired 61,178 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiBiase Mary Chief Operating Officer | 2025-01-23 | Grant or award | +61,178 | 513,238 | D | ||
| DiBiase Mary Chief Operating Officer | 2025-01-24 | Sale | −22,258 | $0.45 | $10,094 | 490,980 | D |
| Open-market sales · 22,258 sh · avg $0.45 · $10,094 | |||||||
Loading xslF345X05/wk-form4_1738019716.xml…